Tag: Stentrode

Synchron enrols first patient in US COMMAND study of endovascular brain-computer...

Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...
synchron stentrode safety

Synchron announces long-term safety results with Stentrode device for severe paralysis

Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...

Brain-computer interface technology opens up “whole new world” of therapies

 “We are starting to help patients in ways that we did not think were possible,” Thomas Oxley (Mount Sinai Hospital, New York, USA) tells...
synchron stentrode safety

Synchron announces US$10 million NIH grant for US COMMAND trial

The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
synchron stentrode safety

Synchron given green light to begin US study of endovascular brain-computer...

The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...

LIVE from SNIS: Endovascular brain-computer interface improves function in paralysed patient

According to late-breaking data presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting, a wireless endovascular brain–computer interface (BCI) “may improve capacity to perform activities in daily living...
synchron funding for stentrode

Synchron secures funding to advance commercialisation of Stentrode

Synchron has been awarded nearly AUD$1M ($990,000) in funding from the Medical Research Future Fund (MRFF), through MTPConnect, the Australian Government’s BioMedTech Horizons (BMTH)...

BIBA Briefings: Novel device seeks to overcome paralysis by “bypassing” nervous...

Synchron recently announced the first successful implant of its minimally-invasive neural interface technology (Stentrode) as part of a trial evaluating the safety and efficacy of...